Oliver P. Peoples - Feb 15, 2024 Form 4 Insider Report for YIELD10 BIOSCIENCE, INC. (YTEN)

Role
President and CEO, Director
Signature
/s/ Megan N. Gates, attorney-in-fact
Stock symbol
YTEN
Transactions as of
Feb 15, 2024
Transactions value $
$60,000
Form type
4
Date filed
2/16/2024, 06:26 PM
Previous filing
Feb 14, 2023
Next filing
Aug 19, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction YTEN Common Stock Award $60K +200K +522.08% $0.30 238K Feb 15, 2024 Direct F1
holding YTEN Common Stock 35.9K Feb 15, 2024 By 401(k) Plan F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The securities awarded are in the form of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest as to 50% of the shares on 8/15/2024 and the remaining 50% on 2/15/2025.
F2 Shares acquired as Issuer matching contribution under the Yield10 Bioscience, Inc. 401(k) Plan.